VENKATA SUBRAMANYAM RAJU PENMETSA

      DIN: 01132098

      For latest information about the director, visit MCA.

      VENKATA SUBRAMANYAM RAJU PENMETSA is a director registered with Ministry of Corporate Affairs. Their Director Identification Number (DIN) is 01132098. VENKATA SUBRAMANYAM RAJU PENMETSA is/has been associated with 21 companies.

      This is just one Director. Want to discover lot more?

      Unlock deeper insights with Prime Research AI

      Companies Associated With

      Company Designation Date of Appointment
      HAIRAV GARDENS LLP Designated Partner 31-Dec-2021
      JANYA GARDENS LLP Designated Partner 31-Dec-2021
      VSR GARDENS LLP Designated Partner 03-Jan-2022
      GNAPIKA GARDENS LLP Designated Partner 03-Jan-2022
      AR GARDENS LLP Designated Partner 03-Jan-2022
      TAGOOR LABORATORIES PRIVATE LIMITED Director 16-Aug-2017
      TAGOOR AQUA TECHNOLOGIES PRIVATE LIMITED Director 17-Nov-2017
      TAGOOR CHEMICALS PRIVATE LIMITED Director 16-Aug-2017
      ANGELS PHARMA INDIA PRIVATE LIMITED Director 01-Nov-2020
      TIBRO PHARMACEUTICALS PRIVATE LIMITED Whole-time director 09-Feb-2024
      BHARGHAVI POLYMERS PRIVATE LIMITED Director 30-Sep-2014
      TAGOOR FEEDS PRIVATE LIMITED Director 15-Jul-2017

      Past Companies Associated With

      Company Designation Date of Appointment Date of Cessation
      TAGOOR LABORATORIES PRIVATE LIMITED Director 31-Jan-2009 06-Feb-2009
      SHRI RAM CHLOROCHEM PRIVATE LIMITED Additional Director 24-Jan-2007 28-Sep-2007
      SHRI RAM CHLOROCHEM PRIVATE LIMITED Director 28-Sep-2007 27-Jul-2010
      TAGOOR AQUA TECHNOLOGIES PRIVATE LIMITED Director 03-Mar-2009 01-Sep-2017
      VASUDHA PHARMA CHEM LIMITED Additional Director 26-Dec-2006 10-Sep-2007
      VASUDHA PHARMA CHEM LIMITED Director 10-Sep-2007 27-Jul-2010
      TAGOOR CHEMICALS PRIVATE LIMITED Director 03-Feb-2009 06-Feb-2009
      SHREE JAYA LABORATORIES PRIVATE LIMITED Director 09-Aug-2011 07-Jan-2015
      TIBRO PHARMACEUTICALS PRIVATE LIMITED Additional Director 11-Nov-2023 12-Feb-2024

      “Assess financial performance of all companies under a director.”

      Explore Prime Research Explore for Sales